The Intersection of Bioinformatics and Cellular Function in Disease Modeling

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2024 | Volume :02 | Issue : 02 | Page : –
By
vector

Mansi Srivastava,

  1. Faculty, Department of Biotechnology, Amity University Gurugram, Haryana, India

Abstract document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_128996’);});Edit Abstract & Keyword

The integration of bioinformatics and cellular biology has revolutionized our understanding of disease mechanisms, offering unprecedented opportunities to model complex biological systems. Bioinformatics is an interdisciplinary field that merges biology, computer science, and statistics, offering advanced tools to analyze vast biological datasets. Cellular functions, including gene expression, protein interactions, and metabolic pathways, form the foundation of physiological and pathological states. Disruptions in these processes can result in diseases like cancer, neurodegenerative conditions, and infectious illnesses. By combining these two disciplines, researchers can develop robust disease models that enhance our understanding of disease progression and aid in the identification of therapeutic targets. This article delves into the intersection of bioinformatics and cellular functions, highlighting its applications in disease modeling. It explores genomics, transcriptomics, and proteomics, emphasizing the role of computational tools in identifying disease-linked mutations, analyzing gene expression patterns, and modeling protein interactions. Case studies, including applications in cancer biology, neurodegenerative disorders, and infectious diseases, illustrate the practical implications of bioinformatics-driven research. Emerging technologies such as single-cell omics, machine learning, and multi-omics integration are transforming the field, enabling more precise and personalized disease models. Despite these advancements, challenges remain. Issues such as data integration, computational limitations, and ethical considerations require attention to ensure the reliability and applicability of bioinformatics approaches. The article also discusses potential solutions, including the development of advanced algorithms, collaborative databases, and interdisciplinary research initiatives. In summary, the convergence of bioinformatics and cellular functions forms a dynamic, rapidly advancing field with immense potential to transform medical research and healthcare. By addressing existing challenges and leveraging emerging technologies, researchers can pave the way for groundbreaking advancements in disease modeling, leading to improved diagnostic tools, targeted therapies, and ultimately, better patient outcomes. This intersection will remain a cornerstone of biomedical innovation in the coming decades.

Keywords: bioinformatic, Cellular functions, protein interactions, transcriptomics, single-cell omics.

[This article belongs to International Journal of Cell Biology and Cellular Functions (ijcbcf)]

How to cite this article:
Mansi Srivastava. The Intersection of Bioinformatics and Cellular Function in Disease Modeling. International Journal of Cell Biology and Cellular Functions. 2024; 02(02):-.
How to cite this URL:
Mansi Srivastava. The Intersection of Bioinformatics and Cellular Function in Disease Modeling. International Journal of Cell Biology and Cellular Functions. 2024; 02(02):-. Available from: https://journals.stmjournals.com/ijcbcf/article=2024/view=0

Full Text PDF

Full Text PDF

References
document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_128996’);});Edit

1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. Journal of molecular biology. 1990 Oct 5;215(3):403-10.
2. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA. Gene ontology: tool for the unification of biology. Nature genetics. 2000 May;25(1):25-9.
3. Ayers KL, Cordell HJ. SNP selection in genome‐wide and candidate gene studies via penalized logistic regression. Genetic epidemiology. 2010 Dec;34(8):879-91.
4. Barabási AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nature reviews genetics. 2011 Jan;12(1):56-68.
5. Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, Kellis M, Marra MA, Beaudet AL, Ecker JR, Farnham PJ. The NIH roadmap epigenomics mapping consortium. Nature biotechnology. 2010 Oct;28(10):1045-8.
6. Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-seq quantification. Nature biotechnology. 2016 May;34(5):525-7.
7. Chatr-Aryamontri A, Oughtred R, Boucher L, Rust J, Chang C, Kolas NK, O’Donnell L, Oster S, Theesfeld C, Sellam A, Stark C. The BioGRID interaction database: 2017 update. Nucleic acids research. 2017 Jan 4;45(D1):D369-79.
8. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R, Miriami E, Karczewski KJ, Hariharan M, Dewey FE, Cheng Y. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012 Mar 16;148(6):1293-307.
9. Uusküla-Reimand L, Lee CA, Oh RH, Klein ZP, Adler N, Alvi SA, Langille E, Pasini E, Cheng KC, Abd-Rabbo D, Hou H. Topoisomerase IIb binding underlies frequently mutated elements in cancer genomes. bioRxiv. 2024:2024-11.
10. Eddy SR. Profile hidden Markov models. Bioinformatics (Oxford, England). 1998;14(9):755-63.
11. Eddy SR. Hidden markov models. Current opinion in structural biology. 1996 Jun 1;6(3):361-5.
12. Beck DE, Agama K, Marchand C, Chergui A, Pommier Y, Cushman M. Synthesis and biological evaluation of new carbohydrate-substituted indenoisoquinoline topoisomerase I inhibitors and improved syntheses of the experimental anticancer agents indotecan (LMP400) and indimitecan (LMP776). Journal of medicinal chemistry. 2014 Feb 27;57(4):1495-512.
13. Finn RD, Attwood TK, Babbitt PC, Bateman A, Bork P, Bridge AJ, Chang HY, Dosztányi Z, El-Gebali S, Fraser M, Gough J. InterPro in 2017—beyond protein family and domain annotations. Nucleic acids research. 2017 Jan 4;45(D1):D190-9.
14. Goecks J, Nekrutenko A, Taylor J, Galaxy Team team@ galaxyproject. org. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome biology. 2010 Aug;11:1-3.
15. Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome biology. 2017 Dec;18:1-5.
16. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic acids research. 2000 Jan 1;28(1):27-30.
17. Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, Gauthier LD. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020 May 28;581(7809):434-43.
18. Kinsella RJ, Kähäri A, Haider S, Zamora J, Proctor G, Spudich G, Almeida-King J, Staines D, Derwent P, Kerhornou A, Kersey P. Ensembl BioMarts: a hub for data retrieval across taxonomic space. Database. 2011 Jan 1;2011:bar030.
19. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nature methods. 2012 Apr;9(4):357-9.
20. Li H, Durbin R. Fast and accurate short read alignment with Burrows–Wheeler transform. bioinformatics. 2009 Jul 15;25(14):1754-60.
21. Wang H, Aragam B, Xing EP. Trade-offs of linear mixed models in genome-wide Association studies. Journal of Computational Biology. 2022 Mar 1;29(3):233-42.
22. MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, Junkins H, McMahon A, Milano A, Morales J, Pendlington ZM. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic acids research. 2017 Jan 4;45(D1):D896-901.
23. Margulies, M., et al. (2005). Genome Sequencing in Microfabricated High-Density Picolitre Reactors. Nature, 437(7057), 376-380.
24. Meyer M, Kircher M. Illumina sequencing library preparation for highly multiplexed target capture and sequencing. Cold Spring Harbor Protocols. 2010 Jun 1;2010(6):pdb-rot5448.
25. O’brien KP, Remm M, Sonnhammer EL. Inparanoid: a comprehensive database of eukaryotic orthologs. Nucleic acids research. 2005 Jan 1;33(suppl_1):D476-80.
26. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, Apweiler R, Haab BB, Simpson RJ, Eddes JS, Kapp EA. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database. Proteomics. 2005 Aug;5(13):3226-45.
27. Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nature biotechnology. 2015 Mar;33(3):290-5.
28. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010 Mar 15;26(6):841-2.
29. Sanger F, Coulson AR. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. Journal of molecular biology. 1975 May 25;94(3):441-8.
30. Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. Global quantification of mammalian gene expression control. Nature. 2011 May 19;473(7347):337-42.
31. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research. 2003 Nov 1;13(11):2498-504.
32. Sims D, Sudbery I, Ilott NE, Heger A, Ponting CP. Sequencing depth and coverage: key considerations in genomic analyses. Nature Reviews Genetics. 2014 Feb;15(2):121-32.
33. Stephens ZD, Lee SY, Faghri F, Campbell RH, Zhai C, Efron MJ, Iyer R, Schatz MC, Sinha S, Robinson GE. Big data: astronomical or genomical?. PLoS biology. 2015 Jul 7;13(7):e1002195.
34. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences. 2005 Oct 25;102(43):15545-50.
35. Sun YV, Hu YJ. Integrative analysis of multi-omics data for discovery and functional studies of complex human diseases. Advances in genetics. 2016 Jan 1;93:147-90.
36. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330.
37. Tomczak K, Czerwińska P, Wiznerowicz M. Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemporary Oncology/Współczesna Onkologia. 2015 Jan;2015(1):68-77.

Regular Issue Subscription Review Article
Volume 02
Issue 02
Received 26/11/2024
Accepted 03/12/2024
Published 26/12/2024
193